CTAP TFA
Product Specifications
Target
Opioid Receptor
Related Pathways
Endocrinology/Hormones, GPCR/G Protein, Neuroscience
Bioactivity
CTAP TFA, a potent and highly selective μ opioid receptor antagonist that effectively crosses the blood-brain barrier, exhibits a significant inhibition concentration (IC50) of 3.5 nM. It demonstrates extraordinary selectivity, being over 1200-fold more specific to μ opioid receptors than to δ opioid (IC50 = 4500 nM) and somatostatin receptors. This compound is primarily leveraged for researching L-DOPA-induced dyskinesia (LID) and opiate overdose or addiction [1] [2].
Molecular Formula
C53H70F3N13O12S2
Molecular Weight
1218.32
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A09946-Fluoro647 100 µg/Vial
Anti-GALNT12 Antibody Picoband® Fluoro647 Conjugated
Sign In for Pricing
View Details 
130484-APC 100 µL
NOVA1 (RNA-Binding Protein Nova-1, Neuro-oncological Ventral Antigen 1, Onconeural Ventral Antigen 1, Nova-1, Paraneoplastic Ri Antigen, Ventral Neuron-specific Protein 1) (APC)
Sign In for Pricing
View Details 
037480-ML550 100 µL
KIT, CT (Y936) (KIT, SCFR, Mast/stem cell growth factor receptor Kit, Piebald trait protein, Proto-oncogene c-Kit, Tyrosine-protein kinase Kit, p145 c-kit, v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog, CD117) (MaxLight 550) discontinued
Sign In for Pricing
View Details